Exoskeleton technology firm Ekso Bionics (Nasdaq: EKSO) shares are trading lower on Tuesday after the company announced it has increased the size of the previously announced public offering to 3.9 million common shares from 975,610 shares of Ekso common stock due to demand.
The shares are priced at $10.25 with the gross proceeds expected to be approximately $40 million. The price represents around a 28% discount on the last close price of $13.07 on Monday.
Ekso Bionics has also granted the underwriters 30-day option to purchase up to an additional 585,366 shares of common stock at the public offering price. H.C. Wainwright & Co is acting as the sole book-running manager for the offering.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
The company expects to use the proceeds for working capital and other general corporate purposes, including repayment of debt, acquisitions, and other business opportunities.
The closing of the offering is expected on or around the 11th of February 2021.
Ekso Bionics shares fell over 20% premarket to $10.34, while they are now priced slightly lower at $10.24 following the open on Wall Street.
